Professional Seasonal Analysis for Trading

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)

Seasonality Analysis

Stocks 27 Years Analyzed

BioCryst Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

27.30%
Avg Annual Return
50.4%
Avg Monthly Win Rate
8/12
Positive Months
27
Years Analyzed

BioCryst Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -1.77%
44%
Weak
February -1.48%
52%
Weak
March 2.62%
37%
Weak
April 2.99%
44%
Weak
May 5.42%
46%
Weak
June 1.56%
54%
Moderate
July BEST 12.87%
62%
Strong
August 8.73%
69%
Strong
September WORST -5.94%
31%
Very Weak
October -4.63%
54%
Weak
November 4.12%
62%
Strong
December 2.81%
50%
Weak

BioCryst Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
88.08
Historical Avg Position
31.87
Deviation
+56.22
Performance
Significantly Above Average

BioCryst Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for BCRX with overlay patterns, custom date ranges, and more.

Create Free Account

BioCryst Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

BioCryst Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for BCRX across multiple timeframes.

Create Free Account

About BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) Seasonality

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, BioCryst Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for BioCryst Pharmaceuticals, Inc. - Common Stock is historically July, with an average return of 12.87% and a win rate of 62%. Conversely, September tends to be the weakest month, averaging -5.94% return.

Looking at the full calendar year, BioCryst Pharmaceuticals, Inc. - Common Stock has an average annual return of 27.30% with an overall monthly win rate of 50.4%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for BioCryst Pharmaceuticals, Inc. - Common Stock has a consistency score of 28.9 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

BioCryst Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)?

Historically, July has been the best month for BioCryst Pharmaceuticals, Inc. - Common Stock, with an average return of 12.87% and a win rate of 62%. However, past performance does not guarantee future results.

What is the worst month for BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)?

Based on historical data, September has been the weakest month for BioCryst Pharmaceuticals, Inc. - Common Stock, with an average return of -5.94%. This is a historical observation and does not guarantee future results.

How reliable is BCRX seasonality data?

The seasonality analysis for BioCryst Pharmaceuticals, Inc. - Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use BioCryst Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.